Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination

Heterologous priming with the ChAdOx1 nCoV-19 vector vaccine followed by boosting with a messenger RNA vaccine (BNT162b2 or mRNA-1273) is currently recommended in Germany, although data on immunogenicity and reactogenicity are not available. In this observational study we show that, in healthy adult...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, Tina, Klemis, Verena, Schub, David, Mihm, Janine, Hielscher, Franziska, Marx, Stefanie, Abu-Omar, Amina, Ziegler, Laura, Guckelmus, Candida, Urschel, Rebecca, Schneitler, Sophie, Becker, Sören L., Gärtner, Barbara C., Sester, Urban, Sester, Martina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2021
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440177/
https://www.ncbi.nlm.nih.gov/pubmed/34312554
http://dx.doi.org/10.1038/s41591-021-01464-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8440177/
https://www.ncbi.nlm.nih.gov/pubmed/34312554
http://dx.doi.org/10.1038/s41591-021-01464-w

Ejemplares similares